Targeted expansion of cytotoxic T cells using IL-12 and CD137L supplementation enhances antitumor efficacy
Open Access
- 14 May 2025
- journal article
- Published by Elsevier in Molecular Therapy Oncology
- Vol. 33 (2) , 200996
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases (R01-AI125097, R21-AI157864, P30AI117970)
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- District of Columbia Developmental Center for AIDS Research
This publication has 91 references indexed in Scilit:
- A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid LeukemiaClinical Lymphoma Myeloma and Leukemia, 2023
- NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functionsCell Reports, 2021
- Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strengthCancer Immunology, Immunotherapy, 2020
- In vitro expansion of Vγ9Vδ2 T cells for immunotherapy2020
- Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapyJournal of Leukocyte Biology, 2019
- Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cellsCancer Letters, 2016
- Human gamma delta T cells: Evolution and ligand recognitionCellular Immunology, 2015
- Impact of age, gender, and race on circulating γδ T cellsHuman Immunology, 2010
- Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumabInternational Journal of Cancer, 2008
- CD16 on human γδ T lymphocytes: Expression, function, and specificity for mouse IgG isotypesCellular Immunology, 1992